Zonk Drug R&d Limited

Country/Region: China     State/Province: Guangdong

Main Products: Propacetamol, Estramustine, Adfovir, Triflusal

Company Introduction
we are good at synthesis,we have a production base in Liaoning province,we will get certified of USA GMP and Eruope COS next year.we are supplying triflusal ;estramustine ;fotemustine;propacetamol;balsalazide and their intermediates now. we intend to build up longterm relationship with customers ,so helping customer to get DMF registration is our main duty .
Company Overview

Business Type: Exporter, Trader

Year Established: 2004

Employees: 501 - 1000 People

Plant Area: 10,000-30,000 square meters

Contact Information

Fax: 86-20-85660382

Business Information

Main Markets: South America 10% Africa 11% Eastern Asia 12% Domestic Market 10% North America 11% Eastern Europe 8% Southern Europe 12% Mid East 10% Northern Europe 11% Oceania 5%

Trade Capacity: FOB, CFR, DES

Contract Manufacturing: Design Service Offered

Nearest Port: guangzhou

Trade & Financial Information

Annual Revenue: Below US$1 Million

Total Revenue: Below US$1 Million

Export Revenue: Above US$100 Million

Annual Output: US$5 Million - US$10 Million

Registered Capital: US$1 Million - US$2.5 Million

Export Percentage: 81% - 90%

Payment Modes: USD, JPY, HKD

Lead Time: 29 days

Import/Export Mode: Have Own Export License

Product Showcase
propacetamol
estramustine
adfovir
triflusal

CL-Link > Health & Medicines in China Health & Medicines in Guangdong Medicines in China Medicines in Guangdong Griseofulvin in China Griseofulvin in Guangdong